124 related articles for article (PubMed ID: 3159011)
1. Differential effects of dopamine D-1 and D-2 agonists and antagonists in 6-hydroxydopamine-lesioned rats.
Arnt J
Psychopharmacology Suppl; 1985; 2():60-1. PubMed ID: 3159011
[No Abstract] [Full Text] [Related]
2. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
Arnt J; Hyttel J
Eur J Pharmacol; 1984 Jul; 102(2):349-54. PubMed ID: 6148252
[TBL] [Abstract][Full Text] [Related]
3. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.
Arnt J; Hyttel J
Psychopharmacology (Berl); 1985; 85(3):346-52. PubMed ID: 2860689
[TBL] [Abstract][Full Text] [Related]
4. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
Fletcher GH; Starr MS
Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
[TBL] [Abstract][Full Text] [Related]
5. Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat.
Fletcher GH; Starr MS
Eur J Pharmacol; 1987 Jun; 138(3):407-11. PubMed ID: 2957221
[TBL] [Abstract][Full Text] [Related]
6. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
7. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
8. Evidence for heterogeneous rotational responsiveness to apomorphine, 3-PPP and SKF 38393 in 6-hydroxydopamine-denervated rats.
Fenton HM; Leszczak E; Gerhardt S; Liebman JM
Eur J Pharmacol; 1984 Nov; 106(2):363-72. PubMed ID: 6442233
[TBL] [Abstract][Full Text] [Related]
9. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
10. Effects of specific D-1 and D-2 dopamine agonists (LY141865 and SKF-38393) and pergolide on urinary output of rats.
Leander JD
Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):290-5. PubMed ID: 2962555
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
Robertson GS; Fine A; Robertson HA
Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
[TBL] [Abstract][Full Text] [Related]
12. Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions.
Arnt J
Life Sci; 1985 Aug; 37(8):717-23. PubMed ID: 3927097
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinities in vitro.
Arnt J; Hyttel J
J Neural Transm; 1986; 67(3-4):225-40. PubMed ID: 2949056
[TBL] [Abstract][Full Text] [Related]
14. Selective inactivation of dopamine D1 and D2 receptors in 6-hydroxydopamine-lesioned rats: evidence that the effect of D1 and D2 agonists can be expressed in the absence of the heterologous DA receptor.
Arnt J; Hyttel J
Pharmacol Toxicol; 1989 Jan; 64(1):116-9. PubMed ID: 2526946
[TBL] [Abstract][Full Text] [Related]
15. MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease.
Morelli M; Di Chiara G
Eur J Pharmacol; 1990 Jul; 182(3):611-2. PubMed ID: 1977595
[No Abstract] [Full Text] [Related]
16. Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.
Braun AR; Barone P; Chase TN
Adv Exp Med Biol; 1986; 204():151-66. PubMed ID: 2947426
[No Abstract] [Full Text] [Related]
17. Neurobiology of D1 dopamine receptors after neonatal-6-OHDA treatment: relevance to Lesch-Nyhan disease.
Breese GR; Mueller RA; Napier TC; Duncan GE
Adv Exp Med Biol; 1986; 204():197-215. PubMed ID: 2947429
[No Abstract] [Full Text] [Related]
18. Chronic levodopa impairs the recovery of dopamine agonist-induced rotational behavior following neural grafting.
Yurek DM; Steece-Collier K; Collier TJ; Sladek JR
Exp Brain Res; 1991; 86(1):97-107. PubMed ID: 1684547
[TBL] [Abstract][Full Text] [Related]
19. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
